Schalop Lee Troy has filed 5 insider transactions across 1 company since August 2025.
Most recent transaction: a purchase of 48544 shares of Lantern Pharma Inc. ($LTRN) on May 12, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | Lantern Pharma Inc. | $LTRN | Schalop Lee Troy | Director | P | Common stock, $0.001 par value | 48544 | $2.06 | 48,544.0000 | 11,184,423 | 9999.99% | 0.43% |
| May 12, 2026 | Lantern Pharma Inc. | $LTRN | Schalop Lee Troy | Director | P | Common stock purchase warrant (Right to Buy) | 48544 | $0.00 | 48,544.0000 | 11,184,423 | 50.00% | 0.43% |
| Jan. 9, 2026 | Lantern Pharma Inc. | $LTRN | Schalop Lee Troy | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 11,184,423 | 9999.99% | 0.22% |
| Jan. 9, 2026 | Lantern Pharma Inc. | $LTRN | Schalop Lee Troy | Director | A | Stock Option (Right to Buy) | 18460 | $0.00 | 18,460.0000 | 11,184,423 | 9999.99% | 0.17% |
| Aug. 19, 2025 | Lantern Pharma Inc. | $LTRN | Schalop Lee Troy | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 10,784,725 | 9999.99% | 0.05% |